Tacedinaline
- Generic Name
- Tacedinaline
- Drug Type
- Small Molecule
- Chemical Formula
- C15H15N3O2
- CAS Number
- 112522-64-2
- Unique Ingredient Identifier
- UMF554N5FG
Overview
Tacedinaline has been used in trials studying the treatment of Lung Cancer, Multiple Myeloma, and Pancreatic Cancer.
Background
Tacedinaline has been used in trials studying the treatment of Lung Cancer, Multiple Myeloma, and Pancreatic Cancer.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath